Download presentation
Presentation is loading. Please wait.
Published byAisha Ackland Modified over 9 years ago
1
The role of glucagon and GLP-1 in the regulation of appetite. Katherine Simpson, Jennifer Parker, Niamh Martin, Ben Field, James Minnion, Mohammad Ghatei and Steve Bloom Dept. Investigative Medicine Academic Trainees Annual Event 5 th May 2011
2
Obesity and type 2 diabetes mellitus 25% of adults in England are obese (BMI>30 kg/m 2 ) (Health and Social Care Information Centre, 2010)
3
Type 2 diabetes Insulin resistance and high circulating glucagon GLP-1 analogues: exenatide, liraglutide GLP-1 and glucagon co-agonism: reduced body weight improved glucose profile marginal reduction in food intake increased energy expenditure (Pocai A et al Oct 2009 and Day JW et al Oct 2009)
4
Gut-brain axis
5
Pre-proglucagon processing
8
Peripherally administered: decreases food intake in animals Peripheral effects prevented by: Vagotomy or lesions in the AP and NTS Human studies: Peripheral administration decreases meal size c-fos peripheral GLP-1: AP, NTS, amygdalaand PVN Glucagon and GLP-1
9
Aims: to answer the following questions (1)What is the effect of co-administration of glucagon and GLP-1 on food intake? (2) Which CNS areas are responsible for this effect?
10
Effects of glucagon on food intake
11
Effects of GLP-1 on food intake
12
‘Subthreshold doses’ of glucagon and GLP-1
13
Co-administration of glucagon and GLP-1 Saline GLP-1 Glucagon combined
14
Question 2: Which CNS areas are responsible for these effects on food intake?
15
AP NTS vagal afferents Brainstem Hypothalamus
16
Glucagon 750 nmol/kg s/c GLP-1 600 nmol/kg s/c Saline s/c 250 uM
17
Dose response c-fos activation in the brainstem following glucagon administration
18
Dose response c-fos activation in the brainstem following GLP-1 administration
19
c-fos activation in the brainstem following co-administration of glucagon and GLP-1
20
No significant differences in hypothalamus Central nucleus of amygdala and reward
21
Summary Co-administration of glucagon and GLP-1: – decreases food intake to a greater degree than either peptide alone – Increases c-fos expression in similar brainstem areas: AP and NTS
22
Future work (1)Food intake and CNS pathways: - which neuronal population (2)Chronic effects of dual receptor agonism: - chronic feeding studies in rodents (3) Effects in humans: - glucagon/GLP-1 co-infusion and the effect on food intake
23
(4) Glucose homeostasis: - glucose tolerance tests (5) Energy expenditure: - calorimetry - BAT mass and UCP-1 mRNA
24
Acknowledgements Professor Steve Bloom Dr Niamh Martin Jenny Parker, Klara Hostomska, Jamie Plumer Dr James Minnion, Dr Ben Field and Dr Tricia Tan Professor Mohammad Ghatei Wellcome Trust
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.